Stephanie Williams

Development of Lipoprotein(a) siRNAs for Mechanism of Action Studies in Non-Human Primate Models of Atherosclerosis

S. Bartz, D. Johns, S. Yendluri, 2015, Journal of Cardiovascular Translational Research.

Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment.

S. Stirdivant, A. Sachs, J. Davide, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkey[S]

S. Bartz, Shirly Pinto, D. McLaren, 2016, Journal of Lipid Research.